Callan JMB Inc. is a vertically integrated logistics and fulfillment company, which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. The Company provides comprehensive alternatives to all logistics solutions and services utilized for frozen shipping in the life sciences industry (personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities that require continuous exposure to cryogenic or frozen temperatures). Its Ship2Q ultraviolet disinfection process (Safe Hygienic Irradiation Performance Process & Qualification) ensures fitness, thermal reliability, and cleanliness of the system components within the manufacturers specifications equal to new off-the-shelf shipper systems.
BörsenkürzelCJMB
Name des UnternehmensCallan JMB Inc
IPO-datumFeb 05, 2025
CEOMr. Wayne D Williams
Anzahl der mitarbeiter10
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 05
Addresse244 Flightline Drive
StadtSPRING BRANCH
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl78070
Telefon18304380395
Websitehttps://callanjmb.com/
BörsenkürzelCJMB
IPO-datumFeb 05, 2025
CEOMr. Wayne D Williams
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten